Proteins and Peptides
10 October 2013
Karolinska Development AB (publ): Pergamum announces final data from Phase I/II study of LL-37 in patients with chronic leg ulcers9 October 2013
Catalyst Biosciences And Isu Abxis Announce Collaboration To Develop Next-Generation Best-In-Class Factor IX Therapeutics8 October 2013
Acorda Therapeutics Announces Initiation of Second Phase 1 GGF2 Clinical Trial in Heart Failure1 October 2013
New Data Analyses Show Significant Clinical and MRI Improvements with PLEGRIDY™ (Peginterferon Beta-1a)30 September 2013
Halozyme Presents PEGPH20 Phase 1b Clinical Trial Data at European Cancer Congress 201330 September 2013
DiaMedica Announces Successful Phase I/II Clinical Results in Type 2 Diabetic Patients28 September 2013
Ipsen : results from CLARINET® Phase III clinical trial showed the antiproliferative effect of Somatuline® in the treatment of non-functioning GEP-NETs27 September 2013
Novo Nordisk – IDegLira improves glycaemic control throughout the day with no weight gain and a low rate of hypoglycaemia25 September 2013
Sobi receives positive CHMP opinion for Kineret® for treatment of rare disease CAPS25 September 2013
Novo Nordisk – enrolment of Victoza® (liraglutide) cardiovascular outcomes trial completed on schedule with patient numbers exceeding target24 September 2013
Data Show Sanofi’s Lyxumia(R) Added to Basal Insulin Lowered Blood Sugar Especially when Fasting Plasma Glucose was Controlled24 September 2013
BioMarin Doses First Patient in Phase 1/2 Trial With BMN 190 for the Treatment of Neuronal Ceroid Lipofuscinosis Type 2, a Form of Batten Disease23 September 2013
Versartis Presents Latest Positive Results From Its Pediatric Study of Long-Acting Growth Hormone Treatment at International Endocrinology Conference23 September 2013
New Data Evaluating Asfotase Alfa in Infants and Young Children with Hypophosphatasia (HPP) Presented at Paediatric Endocrinology Meeting20 September 2013
Novo Nordisk: NovoEight® (turoctocog alfa) receives positive opinion from the European regulatory authoritiesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports